Use of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report

Chondroblastoma is a rare, benign bone tumor that represents 1–2% of all primary bone tumors. Denosumab, a monoclonal antibody, has been demonstrated to inhibit the growth of giant cell tumors. We report a case of recurrent chondroblastoma of the squamous temporal bone that is currently suppressed w...

Descripción completa

Detalles Bibliográficos
Autores principales: Calvert, Nicholas, Wood, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378851/
https://www.ncbi.nlm.nih.gov/pubmed/28396758
http://dx.doi.org/10.1002/ccr3.838
_version_ 1782519492814831616
author Calvert, Nicholas
Wood, David
author_facet Calvert, Nicholas
Wood, David
author_sort Calvert, Nicholas
collection PubMed
description Chondroblastoma is a rare, benign bone tumor that represents 1–2% of all primary bone tumors. Denosumab, a monoclonal antibody, has been demonstrated to inhibit the growth of giant cell tumors. We report a case of recurrent chondroblastoma of the squamous temporal bone that is currently suppressed with denosumab.
format Online
Article
Text
id pubmed-5378851
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-53788512017-04-10 Use of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report Calvert, Nicholas Wood, David Clin Case Rep Case Reports Chondroblastoma is a rare, benign bone tumor that represents 1–2% of all primary bone tumors. Denosumab, a monoclonal antibody, has been demonstrated to inhibit the growth of giant cell tumors. We report a case of recurrent chondroblastoma of the squamous temporal bone that is currently suppressed with denosumab. John Wiley and Sons Inc. 2017-02-23 /pmc/articles/PMC5378851/ /pubmed/28396758 http://dx.doi.org/10.1002/ccr3.838 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Calvert, Nicholas
Wood, David
Use of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report
title Use of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report
title_full Use of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report
title_fullStr Use of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report
title_full_unstemmed Use of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report
title_short Use of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report
title_sort use of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378851/
https://www.ncbi.nlm.nih.gov/pubmed/28396758
http://dx.doi.org/10.1002/ccr3.838
work_keys_str_mv AT calvertnicholas useofdenosumabinrecurrentchondroblastomaofthesquamoustemporalboneacasereport
AT wooddavid useofdenosumabinrecurrentchondroblastomaofthesquamoustemporalboneacasereport

Ejemplares similares